BELINDA OBRIEN: Open Payments
NPI 1104334747 · DENTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,724 in 94 payments from 28 companies in 2025. Trend: 2023 $448 · 2024 $1,390 · 2025 $1,724
Food & beverage: $1,639Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $258 |
| AstraZeneca Pharmaceuticals LP | 13 | $246 |
| Astellas Pharma US Inc | 4 | $148 |
| Corcept Therapeutics | 8 | $137 |
| Novo Nordisk Inc | 6 | $114 |
| Amgen Inc. | 6 | $92 |
| GlaxoSmithKline, LLC. | 4 | $80 |
| Lilly USA, LLC | 5 | $78 |
| Soleno Therapeutics, Inc. | 2 | $52 |
| Lundbeck LLC | 3 | $52 |
Products named: Korlym, QULIPTA, FARXIGA, BREZTRI, MOUNJARO, Veozah, VRAYLAR, Ozempic.
Industry payments across TX — which companies pay providers there.
